Effector Therapeutics Inc (EFTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,768 | 1,204 | 1,468 | N/A | 0 |
| Other current assets | 0 | 0 | 1 | 0 | 0 |
| TOTAL | $58,941 | $1,433 | $1,813 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 21 | N/A | N/A | N/A | N/A |
| Investments And Advances | 0 | 175,008 | 175,004 | 0 | 0 |
| Other Non-Current Assets | 974 | 0 | 0 | 0 | 0 |
| TOTAL | $995 | $175,008 | $175,004 | $N/A | $N/A |
| Total Assets | $59,936 | $176,441 | $176,817 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 321 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 2,748 | 2,105 | 241 | N/A | 0 |
| Other current liabilities | 43,250 | N/A | N/A | N/A | 0 |
| TOTAL | $46,347 | $2,105 | $241 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,663 | N/A | N/A | N/A | 0 |
| Other Non-Current Liabilities | 2,595 | 169,336 | 171,576 | 0 | 0 |
| TOTAL | $21,258 | $169,336 | $171,576 | $N/A | $N/A |
| Total Liabilities | $67,605 | $171,441 | $171,817 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,615 | 902 | 880 | N/A | N/A |
| Common Shares | 4 | 1 | 1 | N/A | 0 |
| Retained earnings | -139,950 | -4,659 | 47 | N/A | 0 |
| TOTAL | $-7,669 | $5,000 | $5,000 | $N/A | $0 |
| Total Liabilities And Equity | $59,936 | $176,441 | $176,817 | $0 | $0 |